EAG discloses conflicts of interest including direct fees for advisory services from: AbbVie, Alexion Pharmaceuticals, Apellis, Celgene/BMS, CTI Biopharma, Genentech, Novartis, Picnic Health, Takeda Oncology, Taiho Oncology, Research Funding to Roswell Park from Astex Pharmaceuticals, AstraZeneca Rare Disease, Alexion Pharmaceuticals, Apellis Pharmaceuticals, Blueprint Medicines, Genentech Inc. and CME/Honoraria payments from Physicians Educational Resource, MediCom Worldwide, American Society of Hematology, AAMDS International Foundation, MDS International Foundation, and the Vera & Joseph Dresner Foundation.